KDM1A and neuroblastoma: However, because the effect of verlindamycin was not recapitulated by neither chemical nor genetic LSD1 inhibitor, we suggest that LSD1 blockade is not enough to enhance the differentiation-inducing potential of ATRA in neuroblastoma.